NewsNovo
The tension is earnings discipline versus top-line weakness.
Procter & Gamble posted non-GAAP earnings per share of $1.43 for the period, beating consensus by $0.02, while revenue of $21.2 billion came in $180 million below what analysts had expected.
Two figures, two stories, neither one resolving the other.
The case for the earnings beat A $0.02 beat on non-GAAP EPS is modest in absolute terms, but it signals that Procter & Gamble held the cost line even as the top line softened.
Keep reading